Enzo: Enzo Biochem to Pay $7.5 Million to Settle Suit Over 2023 Breach
Diagnostic-testing providers Enzo Biochem Inc. would pay $7.5 million to settle allegations it negligently failed to protect the personal information of approximately 2 million people that was exposed in an April 2023 ransomware attack and data breach, under a proposed deal filed in federal court.
Read full article »
Enzo is a New York-based biotechnology company that develops diagnostics tests for the treatment of cancer, diabetes, HIV, uveitis, and inflammatory bowel diseases.
Read more